NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

膀胱過動症治療的全球市場:藥物療法·疾病的種類·及地區別市場規模(2021年∼2027年)

Global Overactive Bladder Treatment Market by Pharmacotherapy, Disease Type, Regional Forecasts 2021-2027

出版商 Bizwit Research & Consulting LLP 商品編碼 1016994
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
膀胱過動症治療的全球市場:藥物療法·疾病的種類·及地區別市場規模(2021年∼2027年) Global Overactive Bladder Treatment Market by Pharmacotherapy, Disease Type, Regional Forecasts 2021-2027
出版日期: 2021年06月23日內容資訊: 英文
簡介

膀胱過動症治療的市場規模,2020年以約40億美元,從2021年開始超越2027年的預測期間一連數天,2.93%的成長率增長。

該市場受到製藥公司積極營銷、創新膀胱內療法的發展、患病率上升、人口老齡化和醫療保健成本上升的推動。另一方面,當前膀胱過度活動症治療的不良全身影響可能會阻礙 2021-2027 年預計期間的市場增長。

本報告提供膀胱過動症治療市場調查,提供市場概要,市場分析,藥物療法·疾病的種類·各地區的分析,及競爭情形等全面性資訊。

目錄

第1章 摘要整理

第2章 全球膀胱過動症治療市場定義和範圍

第3章 全球膀胱過動症治療市場動態

  • 膀胱過動症治療市場影響分析(2019年∼2027年)

第4章 全球膀胱過動症治療市場產業分析

  • 波特的五力分析模式
  • PEST分析
  • 投資採用模式
  • 分析師的推薦事項與結論

第5章 各藥物療法的膀胱過動症治療市場

  • 市場概述
  • 各藥物療法的膀胱過動症治療市場:潛在的分析
  • 各藥物療法的膀胱過動症治療市場估計與預測(2018年∼2027年)(美金)
  • 膀胱過動症治療市場,子區隔分析
    • Anticholinergics
    • Solifenacin
    • Oxybutynin
    • Darifenacin
    • Fesoterodine
    • 其他

第6章 各疾病種類的膀胱過動症治療市場

  • 市場概述
  • 各疾病種類的全球膀胱過動症治療市場:潛在的分析
  • 各疾病種類的全球膀胱過動症治療市場估計與預測(2018年∼2027年)(美金)
  • 膀胱過動症治療市場,子區隔分析
    • 特發性膀胱過活動
    • 神經原因性膀胱的過活動

第7章 各地區的全球膀胱過動症治療市場

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 南美
    • 巴西
    • 墨西哥
  • 其他全球膀胱過動症治療市場

第8章 競爭資訊

  • 頂級市場策略
  • 企業簡介
    • Intas Pharmaceuticals Ltd.
    • Teva Pharmaceutical Industries Limited
    • Aurobindo Pharma Limited
    • Hisamitsu Pharmaceutical Co., Inc.
    • Johnson & Johnson
    • Macleods Pharmaceuticals Ltd.
    • Endo International PLC
    • Mylan N.V.
    • Apotex Inc.
    • Allergan, PLC.

第9章 調查流程

目錄

Global Overactive Bladder Treatment Market is valued approximately at USD 4 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 2.93% over the forecast period 2021-2027. Overactive bladder is a frequent medical condition that causes a sudden need to urinate. Millions of individuals throughout the world suffer from overactive bladder, which is particularly frequent among the elderly. Urine leakage and increased urination frequency, which in patients is about eight times per day, are symptoms of an overactive bladder. Overactive bladder therapy refers to the many therapies used to treat the abrupt, involuntary contraction of the muscle in the urinary bladder wall. The market is driven by Assertive Marketing By Pharma Companies and development of Innovative Intravesical Therapies. For instance, UroGen Pharma Ltd. and The University of Texas MD Anderson Cancer Center announced today a three-year strategic cooperation agreement to enhance combinatorial intravesical immunotherapy for the treatment of high-grade non-muscle invasive bladder cancer. Furthermore, According to the National Association for Incontinence 2020, about 25 million adult Americans suffer with urine incontinence, with women accounting for 75-80% of the cases. On the other side, in 2017, According to the National Association for Incontinence, about 200 million persons worldwide suffered from urine incontinence. Because of the rising prevalence of bladder overactivity, the ageing population, rising healthcare costs, and increased education of overactive bladder treatments. However, Undesired Systemic Effects of Current OAB Treatments, may impede market growth over the forecast period of 2021-2027.

Geographically, the overactive bladder therapy market is expected to be dominated by North America. This is due to the fact that it has a well-established healthcare industry. The market is likely to grow over the forecast period, owing to reimbursement for overactive bladder therapy, increasing geriatric population , and the existence of competitors. However, Asia Pacific is the fastest growing region in the forecasting years 2020-2027.

Major market player included in this report are:

Intas Pharmaceuticals Ltd.

Teva Pharmaceutical Industries Limited

Aurobindo Pharma Limited

Hisamitsu Pharmaceutical Co., Inc.

Johnson & Johnson

Macleods Pharmaceuticals Ltd.

Endo International PLC

Mylan N.V.

Apotex Inc.

Allergan, PLC.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Pharmacotherapy:

Anticholinergics

Solifenacin

Oxybutynin

Darifenacin

Fesoterodine

others

By Diseases type:

Idiopathic Bladder Overactivity

Neurogenic Bladder Overactivity

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027.

Target Audience of the Global Overactive Bladder Treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Overactive Bladder Treatment Market, by Region, 2019-2027 (USD Billion)
    • 1.2.2. Overactive Bladder Treatment Market, by Pharmacotherapy, 2019-2027 (USD Billion)
    • 1.2.3. Overactive Bladder Treatment Market, by Disease type, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Overactive Bladder Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Overactive Bladder Treatment Market Dynamics

  • 3.1. Overactive Bladder Treatment Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Assertive Marketing By Pharma Companies
      • 3.1.1.2. Development of Innovative Intravesical Therapies
    • 3.1.2. Market Restraint
      • 3.1.2.1. Undesired Systemic Effects of Current OAB Treatments
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Novel Treatments, Robust Pipeline, and Patent Cliff of Certain Drugs
      • 3.1.3.2. increasing occurrences of Parkinson's disease, and multiple sclerosis and stroke

Chapter 4. Global Overactive Bladder Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economic
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Overactive Bladder Treatment Market , by Pharmacotherapy

  • 5.1. Market Snapshot
  • 5.2. Global Overactive Bladder Treatment Market by Pharmacotherapy , Performance - Potential Analysis
  • 5.3. Global Overactive Bladder Treatment Market Estimates & Forecasts by Pharmacotherapy 2018-2027 (USD Billion)
  • 5.4. Overactive Bladder Treatment Market , Sub Segment Analysis
    • 5.4.1. Anticholinergics
    • 5.4.2. Solifenacin
    • 5.4.3. Oxybutynin
    • 5.4.4. Darifenacin
    • 5.4.5. Fesoterodine
    • 5.4.6. Others

Chapter 6. Global Overactive Bladder Treatment Market , by Disease type

  • 6.1. Market Snapshot
  • 6.2. Global Overactive Bladder Treatment Market by disease Type, Performance - Potential Analysis
  • 6.3. Global Overactive Bladder Treatment Market Estimates & Forecasts by disease type 2018-2027 (USD Billion)
  • 6.4. Overactive Bladder Treatment Market , Sub Segment Analysis
    • 6.4.1. Idiopathic Bladder Overactivity
    • 6.4.2. Neurogenic Bladder Overactivity

Chapter 7. Global Overactive Bladder Treatment Market , Regional Analysis

  • 7.1. Overactive Bladder Treatment Market , Regional Market Snapshot
  • 7.2. North America Overactive Bladder Treatment Market
    • 7.2.1. U.S. Overactive Bladder Treatment Market
      • 7.2.1.1. Pharmacotherapy breakdown estimates & forecasts, 2018-2027
      • 7.2.1.2. Disease type breakdown estimates & forecasts, 2018-2027
    • 7.2.2. Canada Overactive Bladder Treatment Market
  • 7.3. Europe Overactive Bladder Treatment Market Snapshot
    • 7.3.1. U.K. Overactive Bladder Treatment Market
    • 7.3.2. Germany Overactive Bladder Treatment Market
    • 7.3.3. France Overactive Bladder Treatment Market
    • 7.3.4. Spain Overactive Bladder Treatment Market
    • 7.3.5. Italy Overactive Bladder Treatment Market
    • 7.3.6. Rest of Europe Overactive Bladder Treatment Market
  • 7.4. Asia-Pacific Overactive Bladder Treatment Market Snapshot
    • 7.4.1. China Overactive Bladder Treatment Market
    • 7.4.2. India Overactive Bladder Treatment Market
    • 7.4.3. Japan Overactive Bladder Treatment Market
    • 7.4.4. Australia Overactive Bladder Treatment Market
    • 7.4.5. South Korea Overactive Bladder Treatment Market
    • 7.4.6. Rest of Asia Pacific Overactive Bladder Treatment Market
  • 7.5. Latin America Overactive Bladder Treatment Market Snapshot
    • 7.5.1. Brazil Overactive Bladder Treatment Market
    • 7.5.2. Mexico Overactive Bladder Treatment Market
  • 7.6. Rest of The World Overactive Bladder Treatment Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Intas Pharmaceuticals Ltd.
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Teva Pharmaceutical Industries Limited
    • 8.2.3. Aurobindo Pharma Limited
    • 8.2.4. Hisamitsu Pharmaceutical Co., Inc.
    • 8.2.5. Johnson & Johnson
    • 8.2.6. Macleods Pharmaceuticals Ltd.
    • 8.2.7. Endo International PLC
    • 8.2.8. Mylan N.V.
    • 8.2.9. Apotex Inc.
    • 8.2.10. Allergan, PLC.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Overactive Bladder Treatment Market , report scope
  • TABLE 2. Global Overactive Bladder Treatment Market estimates & forecasts by region 2018-2027 (USD Billion)
  • TABLE 3. Global Overactive Bladder Treatment Market estimates & forecasts by Pharmacotherapy 2018-2027 (USD Billion)
  • TABLE 4. Global Overactive Bladder Treatment Market estimates & forecasts by Disease type 2018-2027 (USD Billion)
  • TABLE 5. Global Overactive Bladder Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 6. Global Overactive Bladder Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 7. Global Overactive Bladder Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global Overactive Bladder Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Overactive Bladder Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Overactive Bladder Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Overactive Bladder Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Overactive Bladder Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Overactive Bladder Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Overactive Bladder Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Overactive Bladder Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. Global Overactive Bladder Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. Global Overactive Bladder Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 18. Global Overactive Bladder Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 19. Global Overactive Bladder Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 20. Global Overactive Bladder Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 21. U.S. Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 22. U.S. Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 23. U.S. Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 24. Canada Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 25. Canada Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 26. Canada Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 27. UK Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 28. UK Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 29. UK Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 30. Germany Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 31. Germany Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 32. Germany Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 33. France Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 34. France Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 35. France Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 36. Spain Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 37. Spain Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 38. Spain Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 39. Italy Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 40. Italy Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 41. Italy Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 42. ROE Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 43. ROE Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 44. ROE Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 45. China Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 46. China Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 47. China Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 48. India Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 49. India Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 50. India Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 51. Japan Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 52. Japan Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 53. Japan Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 54. Australia Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 55. Australia Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 56. Australia Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 57. South Korea Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 58. South Korea Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 59. South Korea Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 60. ROPAC Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 61. ROPAC Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 62. ROPAC Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 63. Brazil Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 64. Brazil Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 65. Brazil Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 66. Mexico Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 67. Mexico Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 68. Mexico Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 69. ROLA Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 70. ROLA Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 71. ROLA Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 72. ROW Overactive Bladder Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 73. ROW Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 74. ROW Overactive Bladder Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 75. List of secondary sources used in the study of global Overactive Bladder Treatment Market .
  • TABLE 76. List of primary sources used in the study of global Overactive Bladder Treatment Market .
  • TABLE 77. Years considered for the study.
  • TABLE 78. Exchange rates considered.

LIST OF FIGURES

List of figures

  • FIG 1. Global Overactive Bladder Treatment Market , research methodology
  • FIG 2. Global Overactive Bladder Treatment Market , market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Overactive Bladder Treatment Market , key trends 2020
  • FIG 5. Global Overactive Bladder Treatment Market , growth prospects 2021-2027
  • FIG 6. Global Overactive Bladder Treatment Market , porters 5 force model
  • FIG 7. Global Overactive Bladder Treatment Market , pest analysis
  • FIG 8. Global Overactive Bladder Treatment Market , value chain analysis
  • FIG 9. Global Overactive Bladder Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Overactive Bladder Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Overactive Bladder Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Overactive Bladder Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Overactive Bladder Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Overactive Bladder Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 15. Global Overactive Bladder Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 16. Global Overactive Bladder Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 17. Global Overactive Bladder Treatment Market , regional snapshot 2018 & 2027
  • FIG 18. North America Overactive Bladder Treatment Market 2018 & 2027 (USD Billion)
  • FIG 19. Europe Overactive Bladder Treatment Market 2018 & 2027 (USD Billion)
  • FIG 20. Asia-Pacific Overactive Bladder Treatment Market 2018 & 2027 (USD Billion)
  • FIG 21. Latin America Overactive Bladder Treatment Market 2018 & 2027 (USD Billion)
  • FIG 22. Global Overactive Bladder Treatment Market , company market share analysis (2020)